Skip to content

The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication

The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03046940
Enrollment
120
Registered
2017-02-08
Start date
2017-03-15
Completion date
2017-06-08
Last updated
2017-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The experiment aims at investigating whether the doctor-patient communication has an influence on patients' willingness to take medication. Patients' attitude towards the medication is manipulated via a critical film sequence. Afterwards patients of the two experimental groups have a communication with one of the investigators of the study. Patients are told that the investigator is a medical doctor. The doctors either communicate in a patient-centered or doctor-centered style with the patient. Patients in the control group do not have the possibility to talk to a medical doctor. Afterwards patients are offered the aforementioned pill that is supposed to be a cognitive enhancer (actually placebo pill). Pill intake is voluntary. The investigators hypothesize that patients in the experimental group with the patient-centered style of communication are more likely to take the pill than patients in the experimental group with the doctor-centered style of communication or patients in the control group.

Interventions

OTHERPatient-centered style of communication

Different doctor-patient communication

OTHERDoctor-centered style of communication

Different doctor-patient communication

Sponsors

Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* female * between 18 and 35 years * healthy * adequate ability to see * fluent in German (reading and writing)

Exclusion criteria

* regular intake of cognitive enhancers/medication that enhances concentration * intake of psychotropic drugs * medical or pharmacy students, advanced psychology students * participants who know the investigators

Design outcomes

Primary

MeasureTime frameDescription
Pill intakeWithin 10 minutes after doctor-patient communicationBehavioural test

Secondary

MeasureTime frameDescription
Willingness to take medication (VAS)Within 10 minutes prior to watching the film sequence, directly (within 5 minutes) after the film sequence, directly (within 10 minutes) after doctor-patient communicationVisual analogue scale (VAS)
Critical attitude towards the medication (VAS)Within 10 minutes prior to watching the film sequence, directly (within 5 minutes) after the film sequence, directly (within 10 minutes) after doctor-patient communicationVisual analogue scale (VAS)
Influence on concentration (Concentration task)Directly (within 10 minutes) after the pill was offeredConcentration task

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026